Lipopolysaccharides d'Escherichia coli 055:B5, purifié par extraction de phénol

Code: l2880-100mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Lipopolysaccharide from Escherichia coli O55:B5 has been used:to stimulate hepatocytes and non-parenchymal cellsto stimulate the spleen and study the exp...


en savoir plus

Votre prix
£214.00 100MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Lipopolysaccharide from Escherichia coli O55:B5 has been used:to stimulate hepatocytes and non-parenchymal cellsto stimulate the spleen and study the expression of the Malitaf gene in the fish blunt snout breamas part of the concanavalin A (ConA) and D-galactosamine/lipopolysaccharide (D-GalN/LPS) model of fulminant hepatitis to study the effect of the natural compound hesperetin

Lipopolysaccharides (LPSs) are characteristic components of the cell wall of Gram-negative bacteria. LPS and its lipid A moiety stimulate cells of the innate immune system by the Toll-like receptor 4 (TLR4), a member of the Toll-like receptor protein family, which recognizes common pathogen-associated molecular-patterns (PAMPs).

Biochem/physiol Actions

Lipid A plays a role in the biological properties attributed to endotoxic LPS. LPS is a highly immunogenic antigen which has the ability to enhance immune responses.

General description

Lipopolysaccharides (LPSs) consist of a lipid A moiety linked to an antigenic O-polysaccharide.

Packaging

25, 100, 500 mg in glass bottle

10 mg in poly bottle

biological sourceEscherichia coli (O55:B5)
formlyophilized powder
impurities﹤3% Protein (Lowry)
purified byphenol extraction
Quality Level300
shipped inambient
storage temp.2-8°C
Code
Description
Unité de vente
Prix annoncé
Qté
L2880-10MG
Unité:10MG
Prix annoncé: £46.80
Source:Prix annoncé
L2880-25MG
Unité:25MG
Prix annoncé: £99.60
Source:Prix annoncé
L2880-500MG
Unité:500MG
Prix annoncé: £852.00
Source:Prix annoncé
Ce produit répond aux critères suivants: